English
Język Polski
MECHANISMS OF RECEPTOR-DEPENDENT REGULATION OF BILE ACID AND XENOBIOTIC METABOLISM. THE ROLE OF CYP3A4 EXPRESSION IN THE SAFETY AND EFFECTIVENESS OF PHARMACOTHERAPY
Grażyna Kubiak-Tomaszewska
Jan Pachecka
Jacek Łukaszkiewicz
Piotr Tomaszewski
Abstract
The isoenzyme CYP3A4 is an important monooxygenase responsible for the metabolism of a large variety of endogenous and exogenous compounds (xenobiotics), including more than 50% of known drugs. The highest activity of CYP3A4 in human was found in hepatocytes and enterocytes. CYP3A4 gene expression is regulated by diverse exogenous and endogenous factors, including bile acids and several drugs, acting via nuclear receptors, such as, for example, PXR or FXR. Understanding the mechanisms of CYP3A4 gene expression is essential for ensuring the safety and effectiveness of pharmacotherapy.
KEYWORDS: CYP3A4, expression, regulation, nuclear receptors, PXR, FXR, xenobiotic biotransformation, drug metabolism, bile acids, pharmacotherapy
Keywords:
CYP3A4, expression, regulation, nuclear receptors, PXR, FXR, xenobiotic biotransformation, drug metabolism, bile acids, pharmacotherapyMost read articles by the same author(s)
- Sylwia Kraczkowska, Zofia Suchocka, Jan Pachecka, ELEVATED BLOOD LEVEL OF HOMOCYSTEINE AS INDICATOR OF HEALTH HAZARD , Prospects in Pharmaceutical Sciences: Vol. 3 No. 3 (2005)
- Marcin Łukasik, Jolanta Karmalska, Mirosław M. Szutowski, Jacek Łukaszkiewicz, EFFECT OF DNA METHYLATION ON GENOME FUNCTION , Prospects in Pharmaceutical Sciences: Vol. 7 No. 2 (2009)
- Jadwiga Piwowarska, Jolanta Felczak, Jacek Łukaszkiewicz, CONCENTRATION OF MALONDIALDEHYDE IN BLOOD AS AN INDICATOR IN LIVER TRANSPLANTATION , Prospects in Pharmaceutical Sciences: Vol. 14 No. 6 (2016)
Similar Articles
- Aleksandra Laskus, Joanna K olmas, NOVEL HYDROXYAPATITE-BASED ANTIBIOTIC DELIVERY SYSTEMS TARGETING BONES , Prospects in Pharmaceutical Sciences: Vol. 14 No. 1 (2016)
- Kinga Grużewska-Piotrowska, Agnieszka Grużewska, Medication overuse headache as a consequence of taking painkillers – a review of current literature , Prospects in Pharmaceutical Sciences: Vol. 21 No. 3 (2023)
- Ewa Napiórkowska, Overview of cyclodextrins and medicinal products containing cyclodextrins currently registered in Poland , Prospects in Pharmaceutical Sciences: Vol. 21 No. 3 (2023)
- Magdalena Bamburowicz-Klimkowska, Urszula Bogucka, Mirosław M. Szutowski, FUNCTIONS OF ATP-BINDING CASSETTE (ABC) TRANSPORTERS , Prospects in Pharmaceutical Sciences: Vol. 9 No. 3 (2011)
- Agata Pisula, Agnieszka Sienicka, Agnieszka Dobrowolska-Redo, Joanna Kacperczyk-Bartnik, Ewa Romejko-Wolniewicz, PARP inhibitors in ovarian cancer therapy , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)
- Martyna Chechłacz, Natalia Korytowska, COMPOUNDS THAT BIND TO PLASMA PROTEINS IN HUMANS. SIGNIFICANCE IN THERAPY AND METHODS FOR QUANTIFICATION OF A FREE FRACTION , Prospects in Pharmaceutical Sciences: Vol. 15 No. 6 (2017)
- Karolina Księżarczyk, Bartłomiej Sankowski, SELECTED ASPECTS OF PARENTERAL NUTRITION , Prospects in Pharmaceutical Sciences: Vol. 15 No. 4 (2017)
- Kacper Jasiński, Paulina Oleksa, Daria Żuraw, Mateusz Sobczyk, Mikołaj Porzak, Alicja Sodolska, Bartosz Pawłowski, The effectiveness of the immune-boosting preparations in prevention and treatment of respiratory infections , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
- Agnieszka Strawa, Ewa Skarżyńska, Barbara Lisowska-Myjak, Can overweight or underweight in young healthy women in the pre-conception period predict disturbed homeostasis of thyroid hormones and protein composition in serum? , Prospects in Pharmaceutical Sciences: Vol. 20 No. 1 (2022)
- Kinga Byk, Filip Charuk, Ewa Olędzka, Marcin Sobczak, Monika Zielińska-Pisklak, CLINICAL APPLICATIONS OF PACLITAXEL IN CANCER THERAPY , Prospects in Pharmaceutical Sciences: Vol. 19 No. 2 (2021)
You may also start an advanced similarity search for this article.
Details
References
Statistics
Authors
Citation rules
Cited by / Share
Licence
This work is licensed under a Creative Commons Attribution 4.0 International License.